IV Iron Shows Only Modest Benefit in HF: HEART-FID

Brasil Notícia Notícia

IV Iron Shows Only Modest Benefit in HF: HEART-FID
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 Medscape
  • ⏱ Reading Time:
  • 70 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 55%

The largest ever study of IV iron supplementation in patients with heart failure failed to meet a new rigorous definition of significance, and the results were generally regarded as disappointing.

Another presentation at the ESC Congress reported a pooled meta-analysis of all the IV iron supplementation studies, including HEART-FID. This showed a significant reduction in one co-primary endpoint but not in the other , which is the more traditional and well-recognized endpoint in heart failure trials.HEART-FID lead investigator, Robert J.

"We need to look further into why there is that discrepancy," he said."This could be a statistical phenomenon or could be something to do with the frequency of re-dosing over the longer term." The primary outcome was a hierarchical composite of death within 12 months after randomization, hospitalizations for heart failure within 12 months after randomization, or change from baseline to 6 months in the 6-minute walk distance. The significance level was set at .01.

Repeated dosing of ferric carboxymaltose appeared to be safe, with an acceptable adverse-event profile in most patients. The number of patients with serious adverse events occurring during the treatment period was similar in the two groups .Designated discussant of the HEART-FID study at the ESC HOTLINE session, Scott Solomon, MD, Brigham and Women's Hospital, Boston, Massachusetts, described HEART-FID as"an extremely important and well-conducted trial.

"When we look at the traditional cardiovascular death/heart failure hospitalization endpoint, one of the hard endpoints that we care about most in heart failure, it's hard to argue that we are not disappointed," he commented.value of .01 threshold set for significance, which is based on new U.S. Food and Drug Administration regulatory standards, Solomon noted,"If they had used a standard=.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Medscape /  🏆 386. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

AUD/JPY Price Analysis: Surrenders modest intraday gains, seems vulnerable to slide furtherAUD/JPY Price Analysis: Surrenders modest intraday gains, seems vulnerable to slide furtherThe AUD/JPY cross attracts some dip-buying near the 93.45 region on Friday and reverses a part of the previous day's retracement slide from over a one
Consulte Mais informação »

Iron Man May Have Predicted An MCU Phase 6 Story 13 Years AgoIron Man May Have Predicted An MCU Phase 6 Story 13 Years AgoJustin Hammer's return was predicted in Iron Man 2.
Consulte Mais informação »

Real-Life Iron Man Suit Reveals 1 Problem The MCU Didn't ShowReal-Life Iron Man Suit Reveals 1 Problem The MCU Didn't ShowIron Man's 2008 suits are still superior.
Consulte Mais informação »

The DCU’s First Villains Make The Evil Iron Man Story The MCU Couldn'tThe DCU’s First Villains Make The Evil Iron Man Story The MCU Couldn'tDC did what the MCU did not.
Consulte Mais informação »

| As Ukraine Advances, Biden Faults| As Ukraine Advances, Biden FaultsKyiv’s troops make a modest breakthrough in the war against Russia, despite U.S. carping.
Consulte Mais informação »

A Mediterranean Lifestyle Really Can Help You Live Longer, Study ShowsA Mediterranean Lifestyle Really Can Help You Live Longer, Study ShowsRich in fruits, vegetables, whole grains, and fish, the Mediterranean diet has long been linked with improving health.
Consulte Mais informação »



Render Time: 2025-02-28 01:34:12